Pembrolizumab
CAS 1374853-91-4
Overview
Pembrolizumab is used in patients with stage III cancer that cannot be treated with surgery, chemotherapy, or radiation therapy. It is also used in patients whose cancer has spread to other parts of the body
Anant Labs manufacture and furnish high quality Pembrolizumab impurities for global markets. Our Pembrolizumab EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
Cat. No.ANT-PBR-000
CAS1374853-91-4
Mol. FormulaC85H170N4OS
Mol. Weight1296.4 g/mol
IUPAClambrolizumab
SMILESCC.CCCCCCCCCCCCC(C)CN(CCCCC=C)CC(CCCCCCCCCCCC)O.CCCCC/C=C/C=C/CCCCCC(C)CN(CCCS)CC(C)CCCCCC/C=C/C=C/CCCC.CCCCN1CCN(CC1)CCC
InChIInChI=1S/C37H69NS.C35H71NO.C11H24N2.C2H6/c1-5-7-9-11-13-15-17-19-21-23-25-27-30-36(3)34-38(32-29-33-39)35-37(4)31-28-26-24-22-20-18-16-14-12-10-8-6-2;1-5-8-11-14-16-18-20-22-24-26-29-34(4)32-36(31-28-13-10-7-3)33-35(37)30-27-25-23-21-19-17-15-12-9-6-2;1-3-5-7-13-10-8-12(6-4-2)9-11-13;1-2/h11,13-18,20,36-37,39H,5-10,12,19,21-35H2,1-4H3;7,34-35,37H,3,5-6,8-33H2,1-2,4H3;3-11H2,1-2H3;1-2H3/b13-11+,16-14+,17-15+,20-18+;;;
InChI KeyAMOIBCKFWIUEKF-NAMKDLAHSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
lambrolizumab
No products available for this API yet. Please check back soon or contact us for custom synthesis.